ING Groep NV Purchases 23,613 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

ING Groep NV increased its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 943.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 26,115 shares of the biotechnology company’s stock after acquiring an additional 23,613 shares during the quarter. ING Groep NV’s holdings in Axon Enterprise were worth $15,521,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of AXON. Concurrent Investment Advisors LLC grew its position in Axon Enterprise by 12.1% in the 4th quarter. Concurrent Investment Advisors LLC now owns 877 shares of the biotechnology company’s stock worth $521,000 after purchasing an additional 95 shares during the last quarter. Hardy Reed LLC acquired a new stake in Axon Enterprise in the 4th quarter worth $220,000. Ieq Capital LLC grew its position in Axon Enterprise by 10.5% in the 4th quarter. Ieq Capital LLC now owns 3,149 shares of the biotechnology company’s stock worth $1,872,000 after purchasing an additional 298 shares during the last quarter. ICICI Prudential Asset Management Co Ltd acquired a new stake in Axon Enterprise in the 4th quarter worth $590,000. Finally, Financial Management Network Inc. grew its position in Axon Enterprise by 10.0% in the 4th quarter. Financial Management Network Inc. now owns 550 shares of the biotechnology company’s stock worth $331,000 after purchasing an additional 50 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Down 9.0 %

Shares of AXON stock opened at $540.00 on Friday. Axon Enterprise, Inc. has a 12-month low of $260.27 and a 12-month high of $715.99. The company has a market capitalization of $41.18 billion, a P/E ratio of 139.54, a P/E/G ratio of 5.95 and a beta of 1.05. The firm has a 50-day moving average price of $622.57 and a 200 day moving average price of $515.53. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. TD Cowen assumed coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target on the stock. Needham & Company LLC raised their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Northland Securities raised their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday. Finally, JMP Securities lifted their target price on shares of Axon Enterprise from $610.00 to $725.00 and gave the company a “market outperform” rating in a research report on Tuesday, February 4th. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $561.31.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the transaction, the director now directly owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Jeffrey C. Kunins sold 2,304 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the completion of the transaction, the insider now directly owns 128,542 shares of the company’s stock, valued at approximately $84,168,016.18. This represents a 1.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 8,711 shares of company stock valued at $5,631,561 in the last ninety days. Insiders own 6.10% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.